Oncopharmpod
CLEOPATRA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:17
- Mas informaciones
Informações:
Sinopsis
Our Landmarks of OncoPharm series returns to discuss the CLEOPATRA study, which established docetaxel, trastuzumab, pertuzumab (THP) as a standard first-line regimen for metastatic HER2-amplified breast cancer.
